BACKGROUND: The clinical characteristics of patients with factor V Leiden or prothrombin
G20210A presenting with a first episode of venous thromboembolism (VTE) have not been …

Factor V Leiden and factor II G20210A mutations are two frequent genetic risk factors
involved in venous thromboembolism (VTE). The goal of this pooled analysis of 8 case …

Summary While Factor V (FV) Leiden is a risk factor for venous thromboembolism (VTE), the
incidence of VTE among FV Leiden carriers is uncertain. The objective of the study was to …

RIETE is an ongoing registry of consecutive patients with acute venous thromboembolism
(VTE). First we learned that in RIETE the prevalence of positive tests was 32%. One in every …

Background: Patients with factor (F) V Leiden or the prothrombin G20210A polymorphism
are at increased risk of developing deep vein thrombosis (DVT). On the other hand, the risk …

Factor V Leiden (FVLeiden) and prothrombin G20210A are the most common genetic
causes of thrombophilia and established risk factors for different clinical manifestations of …

Abstract Factor V Leiden (FVL) and prothrombin G20210A mutation (PTM) are the two most
common genetic polymorphisms known to predispose to a first episode of venous …

Context Testing for genetic risks for venous thromboembolism (VTE) is common, but the
safety and utility of such testing need review. Objectives To define rates of recurrent VTE …

Background Thrombophilia predisposes to venous thromboembolism (VTE) because of
acquired or hereditary factors. Among them, it has been suggested that gene mutations of …

Background: The risk of venous thromboembolism (VTE) during pregnancy in double
heterozygous carriers of factor (F) V Leiden and prothrombin G20210A is not established …